Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06417762 · ClinicalTrials.gov registry record · NA
Dime La VerDAD: Verify, Debunk, and Disseminate
A NA study of COVID-19 and Influenza, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 1,400
- Enrollment target
- 4
- Study locations
NCT06417762: Recruiting NA study of COVID-19 and Influenza, sponsored by University of Chicago.
NCT06417762 is a NA study of COVID-19 and Influenza that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 1,400 participants, below the 38,460-participant average among 298 other COVID-19 trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06417762, a NA study of COVID-19 and Influenza, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,400 participants
- Enrollment target
- 4
- Study locations
Study Summary
Dime la Verdad (Tell me the truth) will evaluate the use of storytelling by community health workers as a communication strategy to disseminate reliable health information on social media and encourage informed decision-making in favor of recommended immunizations in communities with high morbidity and mortality due to respiratory virus infections. Dime La Verdad is an innovative social media capacity-building program based on theoretical frameworks related to health communication that empowers community health workers to disseminate reliable information about respiratory virus protection strategies through the use of personal narratives on social media. The proposed work will use a rigorous stepped wedge design to 1) deliver a scalable program of science communicators using an adapted curriculum grounded in principles of health communication, 2) evaluate how diffusion of health messaging is perceived on social media, and 3) discern how use of personal narratives to enhance science communication can encourage informed decision-making to promote evidence-based immunization practices and improve health outcomes.
Primary Outcome
Community health workers social media followers' intent to use respiratory virus protection strategies. Members of community health workers' social media circles will be surveyed to understand the reach and effectiveness of various types of social media posts. Investigators will measure effectiveness by surveying the social circles of the community health workers six months after the implementation of the curriculum (see recruitment and retention plan), and after the completion of the campaign.
Conditions Studied
Interventions
- BEHAVIORAL Science Communication Curriculum Cohort 1
- BEHAVIORAL Science communication curriculum Cohort 2
- BEHAVIORAL Science communication curriculum Cohort 3
- BEHAVIORAL Science communication curriculum Cohort 4
Study Locations (4)
Illinois
- Rush University - Chicago
- University of Chicago - Chicago
Iowa
- University of Iowa - Iowa City
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2029-04-01 |
| Phase | NA |
What NCT06417762 shows while recruiting
NCT06417762 is an interventional study that assigns participants to a tested intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus, below the 38,460-participant average among 298 other COVID-19 trials with a reported enrollment target (96% lower).
The record links to 5 conditions, with COVID-19 appearing as the primary indexed condition, and to 4 interventions - of which Science Communication Curriculum Cohort 1 is the first listed.
NCT06417762 reports a single indexed study location in Illinois, Iowa, Michigan.
Frequently Asked Questions
What is clinical trial NCT06417762 about?
NCT06417762 is a clinical study titled "Dime La VerDAD: Verify, Debunk, and Disseminate". Dime la Verdad (Tell me the truth) will evaluate the use of storytelling by community health workers as a communication strategy to disseminate reliable health information on social media and encourage informed decision-making in favor of recommended immunizations in communities with high morbidity ...
What is the current status of trial NCT06417762?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,400 participants. The study started on 2024-07-02. Estimated completion is 2029-04-01.
What conditions does trial NCT06417762 study?
This clinical trial studies the following conditions: COVID-19, Influenza, Health Behavior, Communication Research, Respiratory Viral Infection.
What interventions are being tested in trial NCT06417762?
The interventions under investigation include: Science Communication Curriculum Cohort 1 (BEHAVIORAL), Science communication curriculum Cohort 2 (BEHAVIORAL), Science communication curriculum Cohort 3 (BEHAVIORAL), Science communication curriculum Cohort 4 (BEHAVIORAL).
Who is sponsoring clinical trial NCT06417762?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06417762 being conducted?
This trial has 4 study locations across Illinois, Iowa, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06417762's enrollment target sits among peer trials
1,400 57th of 298 higher than 242 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- NCT04250857 · 1,400 participants
HeartStart FRx Defibrillator Event Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI